PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation

The relevance of PCSK9 in atherosclerosis progression is demonstrated by the benefits observed in patients that have followed PCSK9-targeted therapies. The impact of these therapies is attributed to the plasma lipid-lowering effect induced when LDLR hepatic expression levels are recovered after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Luquero, Aureli, Badimon, Lina, Borrell-Pages, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021767/
https://www.ncbi.nlm.nih.gov/pubmed/33834043
http://dx.doi.org/10.3389/fcvm.2021.639727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021767/
https://www.ncbi.nlm.nih.gov/pubmed/33834043
http://dx.doi.org/10.3389/fcvm.2021.639727

Ejemplares similares